Carly Kenselaar

Item: Carly Kenselaar
Rating: 3.2
Author: StockAnalysis.com

Stock Analyst at Citigroup

(3.20)

# 1,121

Out of 5,072 analysts

Total ratings

100%

Success rate

98.64%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$218.00	-19.27%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$35.41	-9.63%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $218.00

Upside: -19.27%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $35.41

Upside: -9.63%